William M. Haskel

Companies

• Paratek Pharmaceuticals, Inc.General counsel Jul 2, 2015 to Sep 21, 2023¹
• Cambrex CorporationSenior Vice President Jun 30, 2011 to Nov 17, 2014²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPParatek Pharmaceuticals, Inc.0 shares³Sep 21, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 21, 2023Returned to company 89,250 shares of Paratek Pharmaceuticals, Inc.³
• Sep 21, 2023Returned to company 357,774 shares of Paratek Pharmaceuticals, Inc.³
• Aug 9, 2023Sold 34,526 shares at $2.20 of Paratek Pharmaceuticals, Inc.⁴
• Aug 8, 2023Granted 73,750 shares of Paratek Pharmaceuticals, Inc.⁴
• Dec 21, 2022Sold 7,007 shares at $1.99 of Paratek Pharmaceuticals, Inc.⁵
• Dec 20, 2022Granted 15,000 shares of Paratek Pharmaceuticals, Inc.⁵
• Dec 13, 2022Sold 23,584 shares at $1.96 of Paratek Pharmaceuticals, Inc.⁶
• Dec 12, 2022Sold 14,410 shares at $1.98 of Paratek Pharmaceuticals, Inc.⁶
• Oct 28, 2022Sold 4,382 shares at $3.47 of Paratek Pharmaceuticals, Inc.⁷
• Oct 25, 2022Granted 9,250 shares of Paratek Pharmaceuticals, Inc.⁸
• Aug 9, 2022Sold 22,453 shares at $2.66 of Paratek Pharmaceuticals, Inc.⁹
• Aug 8, 2022Granted 47,727 shares of Paratek Pharmaceuticals, Inc.⁹
• Mar 15, 2022Granted 67,500 shares of Paratek Pharmaceuticals, Inc.¹⁰
• Dec 15, 2021Sold 17,178 shares at $4.27 of Paratek Pharmaceuticals, Inc.¹¹
• Dec 14, 2021Sold 8,312 shares at $4.37 of Paratek Pharmaceuticals, Inc.¹¹
• Dec 13, 2021Sold 4,876 shares at $4.42 of Paratek Pharmaceuticals, Inc.¹¹